194 related articles for article (PubMed ID: 23519547)
1. Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence.
Xiao Q; Li Q; Zhang B; Yu W
Pediatr Surg Int; 2013 Jun; 29(6):575-81. PubMed ID: 23519547
[TBL] [Abstract][Full Text] [Related]
2. Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome.
Schupp CJ; Kleber JB; Günther P; Holland-Cunz S
Pediatr Dermatol; 2011; 28(6):640-644. PubMed ID: 21995836
[TBL] [Abstract][Full Text] [Related]
3. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Radiological Evaluation of Periocular Infantile Hemangioma Treated With Oral Propranolol: A Case Series.
Ginguerra MA; Saito O; Fernandes JBVD; Castro DS; Matayoshi S
Am J Ophthalmol; 2018 Jan; 185():48-55. PubMed ID: 29103963
[TBL] [Abstract][Full Text] [Related]
5. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
[TBL] [Abstract][Full Text] [Related]
6. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
[TBL] [Abstract][Full Text] [Related]
7. Scoring the therapeutic effects of oral propranolol for infantile hemangioma: A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS).
Janmohamed SR; van Oosterhout M; de Laat PC; van Rosmalen J; Madern GC; Oranje AP
J Am Acad Dermatol; 2015 Aug; 73(2):258-63. PubMed ID: 26183969
[TBL] [Abstract][Full Text] [Related]
8. Low-dose propranolol for infantile hemangioma of the head and neck: Analysis of 23 consecutive patients.
Ren W; Li S; Gao L; Huang S; Zhang L; Qiang C; Liu C; Zhi K
Pediatr Int; 2017 Feb; 59(2):213-217. PubMed ID: 27473874
[TBL] [Abstract][Full Text] [Related]
9. Update on infantile hemangiomas.
Lee KC; Bercovitch L
Semin Perinatol; 2013 Feb; 37(1):49-58. PubMed ID: 23419763
[TBL] [Abstract][Full Text] [Related]
10. Thirty-two Japanese cases of infantile hemangiomas treated with oral propranolol.
Kagami S; Kaneko M; Katori T
J Dermatol; 2018 Jun; 45(6):719-722. PubMed ID: 29603774
[TBL] [Abstract][Full Text] [Related]
11. Recurrence rate of infantile hemangioma after oral propranolol therapy.
Frongia G; Byeon JO; Mehrabi A; Günther P
Eur J Pediatr; 2021 Feb; 180(2):585-590. PubMed ID: 33188478
[TBL] [Abstract][Full Text] [Related]
12. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
[TBL] [Abstract][Full Text] [Related]
13. Monitoring oral propranolol for infantile hemangiomata.
Bar J; Bar-Ilan E; Cleper R; Sprecher E; Samuelov L; Mashiah J
Dermatol Ther; 2022 Nov; 35(11):e15870. PubMed ID: 36177767
[TBL] [Abstract][Full Text] [Related]
14. Oral propranolol for treatment of periocular infantile hemangiomas.
Missoi TG; Lueder GT; Gilbertson K; Bayliss SJ
Arch Ophthalmol; 2011 Jul; 129(7):899-903. PubMed ID: 21402978
[TBL] [Abstract][Full Text] [Related]
15. Preliminary experiences in treating infantile hemangioma with propranolol.
Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
[TBL] [Abstract][Full Text] [Related]
16. The use of propranolol for complicated infantile hemangiomas.
Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Results of Oral Propranolol Treatment Protocol for Periocular Infantile Hemangioma: Should There Be Any Contraindication?
Ghahvehchian H; Kashkouli MB; Ghanbari S; Karimi N; Abdolalizadeh P; Abri Aghdam K
Ophthalmic Plast Reconstr Surg; 2024 Jan-Feb 01; 40(1):61-69. PubMed ID: 38241619
[TBL] [Abstract][Full Text] [Related]
18. Propranolol for the treatment of orbital infantile hemangiomas.
Fridman G; Grieser E; Hill R; Khuddus N; Bersani T; Slonim C
Ophthalmic Plast Reconstr Surg; 2011; 27(3):190-4. PubMed ID: 21283032
[TBL] [Abstract][Full Text] [Related]
19. Combined low-dose oral propranolol and oral prednisolone as first-line treatment in periocular infantile hemangiomas.
Koay AC; Choo MM; Nathan AM; Omar A; Lim CT
J Ocul Pharmacol Ther; 2011 Jun; 27(3):309-11. PubMed ID: 21542771
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
Xue L; Sun C; Xu DP; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]